Page last updated: 2024-08-17

quinoxalines and Psychoses

quinoxalines has been researched along with Psychoses in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fatemi, SH; Folsom, TD; Kneeland, RE; Liesch, SB; Thuras, PD; Yousefi, MK1
Cornwell, J; Davis, JM; Gupta, S; Lajtha, A; Lindenmayer, JP; Noth, K; Sershen, H; Smith, RC1
DiPaula, BA; Thomas, MD1
Liu, ME; Tsai, SJ; Yang, ST1
May, AC; Rose, D1
Akdag, ST; Cinemre, B; Doganavsargil, O; Metin, O1
Buchanan, RW; Fuller, RL; Heishman, SJ; Hong, LE; McMahon, RP; Myers, C; Nye, A; Rachbeisel, J; Summerfelt, A; Thaker, GK; Wonodi, I; Yang, J1
Anthenelli, RM; George, TP; Morris, CD; Thompson, JR; Treadow, J; Williams, JM; Yunis, C1
Baker, AL; Castle, D; Filia, SL; Harris, D; Pirola-Merlo, AJ; Richmond, R1

Trials

5 trial(s) available for quinoxalines and Psychoses

ArticleYear
Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: a double-blind placebo and bupropion-controlled study.
    Schizophrenia research, 2013, Volume: 146, Issue:1-3

    Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzazepines; Bupropion; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotinic Agonists; Psychiatric Status Rating Scales; Psychotic Disorders; Quinoxalines; Schizophrenia; Smoking; Varenicline

2013
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
    Schizophrenia research, 2009, Volume: 110, Issue:1-3

    Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzazepines; Carbon Dioxide; Cognition; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quinoxalines; Schizophrenia; Schizophrenic Psychology; Smoking; Time Factors; Varenicline

2009
Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.
    Archives of general psychiatry, 2011, Volume: 68, Issue:12

    Topics: Adult; Attention; Benzazepines; Biomarkers; Cognition; Double-Blind Method; Eye Movements; Female; Humans; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Sensory Gating; Smoking; Varenicline

2011
A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    The Journal of clinical psychiatry, 2012, Volume: 73, Issue:5

    Topics: Adolescent; Adult; Aged; Benzazepines; Canada; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Schizophrenia; Smoking Cessation; United States; Varenicline

2012
Varenicline plus healthy lifestyle intervention for smoking cessation in psychotic disorders.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2012, Volume: 24, Issue:4

    Topics: Adult; Benzazepines; Bipolar Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Humans; Life Style; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Schizophrenia; Severity of Illness Index; Smoking; Smoking Cessation; Varenicline

2012

Other Studies

4 other study(ies) available for quinoxalines and Psychoses

ArticleYear
Worsening psychosis induced by varenicline in a hospitalized psychiatric patient.
    Pharmacotherapy, 2009, Volume: 29, Issue:7

    Topics: Benzazepines; Bipolar Disorder; Female; Humans; Middle Aged; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Smoking Cessation; Varenicline

2009
Varenicline-induced mixed mood and psychotic episode in a patient with Schizoaffective Disorder.
    CNS spectrums, 2009, Volume: 14, Issue:7

    Topics: Adult; Affective Disorders, Psychotic; Benzazepines; Humans; Male; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Varenicline

2009
Varenicline withdrawal-induced delirium with psychosis.
    The American journal of psychiatry, 2010, Volume: 167, Issue:6

    Topics: Adult; Benzazepines; Delirium; Female; Humans; Nicotinic Agonists; Psychotic Disorders; Quinoxalines; Substance Withdrawal Syndrome; Varenicline

2010
Varenicline-induced Psychosis.
    CNS spectrums, 2010, Volume: 15, Issue:7

    Topics: Benzazepines; Humans; Psychotic Disorders; Quinoxalines; Varenicline

2010